Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9

International Journal of Oncology

Volumn 36, Issue 5, 2010, Pages 1113-1120

  Chen, Ya Yin ^a,b   Chiang, Su Yin ^a   Lin, Jaung Geng ^a   Ma, Yi Shih ^a,c   Liao, Ching Lung ^a   Weng, Shu Wen ^a   Lai, Tung Yuan ^a,b   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Chang Hua Hospital   (Taiwan)

Author keywords

Aloe emodin; Emodin; Human tongue cancer SCC 4 cells; Invasion; Matrix metalloproteinases; Migration; Rhein

Indexed keywords

ALOE EMODIN; EMODIN; GELATINASE A; GELATINASE B; RHEIN; UROKINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INVASION; CELL CYCLE ARREST; CHINESE MEDICINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; RHUBARB; TONGUE CANCER; WESTERN BLOTTING; ZYMOGRAPHY;

ALOE; ANTHRAQUINONES; CELL LINE, TUMOR; CELL MOVEMENT; DRUG SCREENING ASSAYS, ANTITUMOR; EMODIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; RNA, MESSENGER; TONGUE NEOPLASMS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77950455995     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000593     Document Type: Article

References (38)

1. Tsai TH and Chen CF: Ultraviolet spectrum identification of emodin in rabbit plasma by HPLC and its pharmacokinetics application. Asia Pac J Pharmacol 7: 53-56, 1992.
2. Liang JW, Hsiu SL, Huang HC and Lee-Chao PD: HPLC analysis of emodin in serum, herbs and Chinese herbal prescriptions. J Food Drug Anal 1: 251-257, 1993.
3. Yang F, Zhang T, Tian G, Cao H, Liu Q and Ito Y: Preparative isolation and purification of hydroxyanthraquinones from Rheum officinale Baill by high-speed counter-current chromatography using pH-modulated stepwise elution. J Chromatogr A 858: 103-107, 1999.
4. Huang HC, Chu SH and Chao PD: Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol 198: 211-213, 1991.
5. +-ATPase of the rabbit renal medulla and their diuretic action. Yao Xue Xue Bao 23: 17-20, 1988.
6. Koyama M, Kelly TR and Watanabe KA: Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies. J Med Chem 31: 283-284, 1988.
7. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M and Palu G: Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 60: 2800-2804, 2000.
8. Miccadei S, Pulselli R and Floridi A: Effect of lonidamine and rhein on the phosphorylation potential generated by respiring rat liver mitochondria. Anticancer Res 13: 1507-1510, 1993.
9. Delpino A, Paggi MG, Gentile PF, Castiglione S, Bruno T, Benass M and Floridi A: Protein synthetic activity and adenylate energy charge in Rhein-treated cultured human glioma cells. Cancer Biochem Biophys 12: 241-252, 1992.
10. Castiglione S, Fanciulli M, Bruno T, Evangelista M, Del Carlo C, Paggi MG, Chersi A and Floridi A: Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions. Anticancer Drugs 4: 407-414, 1993.
11. Lin SY, Lai WW, Ho CC, Yu FS, Chen GW, Yang JS, Liu KC, Lin ML, Wu PP, Fan MJ and Chung JG: Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 29: 327-335, 2009.
12. Chiu TH, Lai WW, Hsia TC, Yang JS, Hsu CK, Wang CK, Chang CY, Yeh CC, Ho CC, Lu HF, Wood WG and Chung JG: Aloe-emodin induces cell death through S-phase arrest and caspase-dependent pathways in human tongue squamous cancer SCC-4 cells. Anticancer Res (In press).
13. Lai WW, Yang JS, Lai KC, Kuo CL, Hsu CK, Wang CK, Chang CY, Lin JJ, Tang NY, Chen PY, Huang WW and Chung JG: Rhein induced apoptosis through the endoplasmic reticulum stress, caspase- and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells. In Vivo 23: 309-316, 2009.
14. Kilian M, Gregor JI, Heukamp I, Hanel M, Ahlgrimm M, Schimke I, Kristiansen G, Ommer A, Walz MK, Jacobi CA and Wenger FA: Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer. Prostaglandins Leukot Essent Fatty Acids 75: 429-434, 2006.
15. Mizutani K, Kofuji K, and Shirouzu K: The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer. Surg Today 30: 614-621, 2000.
16. Gullu IH, Kurdoglu M and Akalin I: The relation of gelatinase (MMP-2 and -9) expression with distant site metastasis and tumour aggressiveness in colorectal cancer. Br J Cancer 82: 249, 2000.
17. Okuducu AF, Zils U, Michaelis SA, Michaelides S and von Deimling A: Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology 48: 836-845, 2006.
18. Hollborn M, Stathopoulos C, Steffen A, Wiedemann P, Kohen L and Bringmann A: Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci 48: 4360-4367, 2007.
19. Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, Adley BP, Stack MS and Hudson LG: Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 68: 4606-4613, 2008.
20. Bernhard EJ, Gruber SB and Muschel RJ: Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 91: 4293-4297, 1994.
21. Guruvayoorappan C and Kuttan G: Amentoflavone inhibits experimental tumor metastasis through a regulatory mechanism involving MMP-2, MMP-9, prolyl hydroxylase, lysyl oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and cytokines in lung tissues of C57BL/6 mice. Immunopharmacol Immunotoxicol 30: 711-727, 2008.
22. Waas ET, Wobbes T, Lomme RM, DeGroot J, Ruers T and Hendriks T: Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90: 1556-1564, 2003.
23. Okada N, Ishida H, Murata N, Hashimoto D, Seyama Y and Kubota S: Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer 42. Biochem Biophys Res Commun 288: 212-216, 2001.
24. Lin S, Li JJ, Fujii M and Hou DX: Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway. Int J Oncol 22: 829-833, 2003.
25. Wolfle D, Schmutte C, Westendorf J and Marquardt H: Hydroxyanthraquinones as tumor promoters: enhancement of malignant transformation of C3H mouse fibroblasts and growth stimulation of primary rat hepatocytes. Cancer Res 50: 6540-6544, 1990.
26. Pecere T, Sarinella F, Salata C, Gatto B, Bet A, Dalla Vecchia F, Diaspro A, Carli M, Palumbo M and Palu G: Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. Int J Cancer 106: 836-847, 2003.
27. Kuo PL, Lin TC and Lin CC: The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci 71: 1879-1892, 2002.
28. Hsu SC, Yang JS, Kuo CL, Lo C, Lin JP, Hsia TC, Lin JJ, Lai KC, Kuo HM, Huang LJ, Kuo SC, Wood WG and Chung JG: Novel quinolone CHM-1 induces apoptosis and inhibits metastasis in a human osterogenic sarcoma cell line. J Orthop Res (In press).
29. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett (In press).
30. Lu HF, Yang JS, Lai KC, Hsu SC, Hsueh SC, Chen YL, Chiang JH, Lu CC, Lo C, Yang MD and Chung JG: Curcumin-induced DNA damage and inhibited DNA repair genes expressions in mouse-rat hybrid retina ganglion cells (N18). Neurochem Res 34: 1491-1497, 2009.
31. Thomas GT, Lewis MP and Speight PM: Matrix metallo-proteinases and oral cancer. Oral Oncol 35: 227-233, 1999.
32. Tryggvason K, Hoyhtya M and Salo T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191-217, 1987.
33. Stacker SA, Achen MG, Jussila L, Baldwin ME and Alitalo K: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2: 573-583, 2002.
34. Pepper MS: Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21: 1104-1117, 2001.
35. Aguirre Ghiso JA, Alonso DF, Farias EF, Gomez DE and de Kier Joffe EB: Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem 263: 295-304, 1999.
36. Westermarck J and Kahari VM: Regulation of matrix metallo-proteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
37. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS and Lovett DH: A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 369: 485-496, 2003.
38. Philip S and Kundu GC: Osteopontin induces nuclear factor kappa B mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) downregulates these pathways. J Biol Chem 278: 14487-14497, 2003.